MGMT-UNMETHYLATED GLIOBLASTOMA
Clinical trials for MGMT-UNMETHYLATED GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new MGMT-UNMETHYLATED GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for MGMT-UNMETHYLATED GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered t cells take on deadly brain tumors in first human test
Disease control Recruiting nowThis early-stage trial tests a new cell therapy called E-SYNC CAR T cells for people with a specific form of glioblastoma, an aggressive brain cancer. The treatment uses a patient's own immune cells, modified in a lab to better recognize and attack the tumor. About 20 adults will…
Matched conditions: MGMT-UNMETHYLATED GLIOBLASTOMA
Phase: PHASE1 • Sponsor: Hideho Okada, MD, PhD • Aim: Disease control
Last updated May 26, 2026 04:25 UTC
-
New combo therapy aims to outsmart deadly brain cancer
Disease control Recruiting nowThis study tests whether adding the drug WP1066 to standard radiation therapy can help people with a newly diagnosed, aggressive brain cancer called glioblastoma. The drug targets a protein that helps the tumor grow and hide from the immune system. About 39 adults will take part …
Matched conditions: MGMT-UNMETHYLATED GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 19, 2026 11:48 UTC